Malin Corporation PLC (MLC)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell

€8.00

Buy

€9.80

arrow-down€-0.50 (-5.75%)

Prices updated at 12 May 2025, 16:30 BST
| Prices minimum 15 mins delay
|
Prices in EUR
Malin Corporation PLC is a global life sciences company. The firm's investee companies are in science and discovery, clinical and commercial sectors.
FTSE EuroFirst 300
arrow-up1.29%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Liam Daniel
CEO
-
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
3
Head office
50 Richmond Street South
Dublin
Ireland
D02 FK02
mobile
+353 19015700
letter
-
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Christopher Pedrick
Non-Executive Director
-
Dr. Jean-Michel Cossery
Non-Executive Independent Director
-
Dr. Kirsten Drejer
Non-Executive Independent Director
-
Fiona Dunlevy
Executive Director and Company Secretary
-
Liam Daniel
Non-Executive Chairman of the Board
-
Rudy Mareel
Non-Executive Lead Independent Director
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
No data

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
No data
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.